［1］Bukowski RM.Natural history and therapy of metastatic renal cell carcinoma：The role of interleukin-2［J］.Cancer，2015，80(7)：1198-1220.
[2]Fouillade C，Baron-Menguy C，Domenga-Denier V，et al.Transcriptome analysis for Notch3 target genes identifies Grip2 as a novel regulator of myogenic response in the cerebrovasculature［J］.Arterioscler Thromb Vasc Biol，2013，33(1)：76-86.
[3]Wang Z，Li Y，Banerjee S，et al.Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth，migration and invasion，and induces apoptosis via inactivation of Akt，mTOR，and NF-kappaB signaling pathways［J］.J Cell Biochem，2016，109(4)：726-736.
[4]Ye QF，Zhang YC，Peng XQ，et al.siRNA-mediated silencing of Notch-1 enhances docetaxel induced mitotic arrest and apoptosis in prostate cancer cells［J］.Asian Pac J Cancer Prev，2012，13(6)：2485-2489.
[5]Gu Lei，Jiao Ting，Liu Guimin，et al.PTEN and Nocth signaling pathways and non-small cell lung cancer［J］.Modern Oncology，2016，24(14)：2323-2326.［谷蕾，焦婷，刘贵敏，等.PTEN和Nocth信号通路与非小细胞肺癌的关系［J］.现代肿瘤医学，2016，24(14)：2323-2326.］
[6]Hanlon L，Avila JL，Demarest RM，et al.Notch1 functions as a tumor suppressor in a model of K-ras-induced pancreatic ductal adenocarcinoma［J］.Cancer Res，2013，70(11)：4280-4286.
[7]Xu L，Zhu Y，Xu J，et al.Notch1 activation promotes renal cell carcinoma growth via PI3K/Akt signaling［J］.Cancer Sci，2012，103(7)：1253-1258.
[8]Palomero T，Sulis ML，Cortina M，et al.Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia［J］.Nature Medicine，2015，13(10)：1203-1210.
[9]Doroquez DB，Rebay I.Signal integration during development：Mechanisms of EGFR and Notch pathway function and cross-talk［J］.Crit Rev Biochem Mol Biol，2016，41(6)：339-385.
[10]Dai J，Ma D，Zang S，et al.Cross-talk between Notch and EGFR signaling in human breast cancer cells［J］.Cancer Invest，2013，27(5)：533-540.
[11]Wang RA，Li ZS.Tumor related genes change may not promote cancer［J］.Chin J Pathol，2013，42(11)：791-792.［王瑞安，李增山.肿瘤相关基因的改变未必都促癌［J］.中华病理学杂志，2013，42(11)：791-792.］
[12]McGranahan N，Furness AJ，Rosenthal R，et al.Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade［J］.Science，2016，351(6280)：1463-1469.
[13]Fu DF，Liang Y，Qin JH，et al.The antiapoptotic "oncogene" Bcl-2 is a de facto tumor suppressor［J］.Negative，2016，7（5）：34-37.［付大富，梁媛，覃君慧，等.抗凋亡的的“原癌基因”Bcl-2实为抑癌基因［J］.医学争鸣，2016，7（5）：34-37.］